| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ayumi E Pottenger, Mitchell J Bartlett, Scott J Sherman, Torsten Falk, Helena W Morriso. Evaluation of microglia in a rodent model of Parkinson's disease primed with L-DOPA after sub-anesthetic ketamine treatment. Neuroscience letters. vol 765. 2021-12-03. PMID:34536508. |
parkinson's disease (pd) is a neurodegenerative disease caused by the death of dopaminergic neurons in the substantia nigra pars compacta (snpc), characterized by motor dysfunction. |
2021-12-03 |
2023-08-13 |
rat |
| Hongli Li, Yaru Feng, Ziyu Chen, Xi Jiang, Zhenyu Zhou, Jinfeng Yuan, Fei Li, Yu Zhang, Xingxu Huang, Shengjie Fan, Xiaojun Wu, Cheng Huan. Pepper component 7-ethoxy-4-methylcoumarin, a novel dopamine D2 receptor agonist, ameliorates experimental Parkinson's disease in mice and Caenorhabditis elegans. Pharmacological research. vol 163. 2021-11-18. PMID:33007422. |
parkinson's disease (pd) is a progressive neurodegenerative disease resulting from the degeneration of dopaminergic (daergic) neurons in the substantia nigra pars compacta (snpc) and subsequent deficit of dopamine in the striatum. |
2021-11-18 |
2023-08-13 |
mouse |
| Ruixian Xing, Xuewen Liu, Buxian Tian, Yan Cheng, Longguang L. Neuroprotective effect of Na Drug development research. vol 82. issue 7. 2021-11-15. PMID:33538000. |
neuroprotective effect of na parkinson's disease (pd) is a disabling neurodegenerative disease mainly caused by degeneration of mesencephalic dopaminergic neurons in the substantia nigra pars compacta (snpc). |
2021-11-15 |
2023-08-13 |
Not clear |
| Tapan Behl, Piyush Madaan, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Saurabh Bhatia, Ahmed Al-Harrasi, Sridevi Chigurupati, Ibrahim Alrashdi, Simona Gabriela Bunga. Elucidating the Neuroprotective Role of PPARs in Parkinson's Disease: A Neoteric and Prospective Target. International journal of molecular sciences. vol 22. issue 18. 2021-11-01. PMID:34576325. |
one of the utmost frequently emerging neurodegenerative diseases, parkinson's disease (pd) must be comprehended through the forfeit of dopamine (da)-generating nerve cells in the substantia nigra pars compacta (sn-pc). |
2021-11-01 |
2023-08-13 |
Not clear |
| Alexandre Vallée, Jean-Noël Vallée, Yves Lecarpentie. Parkinson's Disease: Potential Actions of Lithium by Targeting the WNT/β-Catenin Pathway, Oxidative Stress, Inflammation and Glutamatergic Pathway. Cells. vol 10. issue 2. 2021-10-15. PMID:33503974. |
parkinson's disease (pd) is one of the major neurodegenerative diseases (nd) which presents a progressive neurodegeneration characterized by loss of dopamine in the substantia nigra pars compacta. |
2021-10-15 |
2023-08-13 |
Not clear |
| Henrik Renner, Hans R Schöler, Jan M Brude. Combining Automated Organoid Workflows With Artificial Intelligence-Based Analyses: Opportunities to Build a New Generation of Interdisciplinary High-Throughput Screens for Parkinson's Disease and Beyond. Movement disorders : official journal of the Movement Disorder Society. 2021-09-20. PMID:34498298. |
parkinson's disease (pd) is the second most common neurodegenerative disease and primarily characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta of the midbrain. |
2021-09-20 |
2023-08-13 |
human |
| Mustafa T Ardah, Greeshma Bharathan, Tohru Kitada, M Emdadul Haqu. Ellagic Acid Prevents Dopamine Neuron Degeneration from Oxidative Stress and Neuroinflammation in MPTP Model of Parkinson's Disease. Biomolecules. vol 10. issue 11. 2021-09-02. PMID:33172035. |
parkinson's disease (pd) is one of the most common neurodegenerative diseases and is characterized by progressive dopaminergic neurodegeneration in the substantia nigra pars compacta area. |
2021-09-02 |
2023-08-13 |
Not clear |
| Luca Magistrelli, Elena Contaldi, Cristoforo Com. The Impact of Life (Basel, Switzerland). vol 11. issue 8. 2021-08-31. PMID:34440548. |
the impact of parkinson's disease (pd) is a common and progressive neurodegenerative disease, caused by the loss of dopaminergic neurons in the substantia nigra pars compacta in the midbrain, which is clinically characterized by a constellation of motor and non-motor manifestations. |
2021-08-31 |
2023-08-13 |
Not clear |
| Victor A D Holanda, Julia J Didonet, Manara B B Costa, Adriano H do Nascimento Rangel, Edilson D da Silva, Elaine C Gaviol. Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease. Pharmaceuticals (Basel, Switzerland). vol 14. issue 8. 2021-08-31. PMID:34451872. |
parkinson disease (pd) is a neurodegenerative disease mainly characterized by the loss of nigral dopaminergic neurons in the substantia nigra pars compacta. |
2021-08-31 |
2023-08-13 |
rat |
| Eun-Mi Hur, Byoung Dae Le. LRRK2 at the Crossroad of Aging and Parkinson's Disease. Genes. vol 12. issue 4. 2021-08-16. PMID:33805527. |
parkinson's disease (pd) is a heterogeneous neurodegenerative disease characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta and the widespread occurrence of proteinaceous inclusions known as lewy bodies and lewy neurites. |
2021-08-16 |
2023-08-13 |
Not clear |
| Alexandre Vallée, Jean-Noël Vallée, Yves Lecarpentie. Potential role of cannabidiol in Parkinson's disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation. Aging. vol 13. issue 7. 2021-08-16. PMID:33848261. |
parkinson's disease (pd) is a major neurodegenerative disease (nd), presenting a progressive degeneration of the nervous system characterized by a loss of dopamine in the substantia nigra pars compacta. |
2021-08-16 |
2023-08-13 |
Not clear |
| Falaq Naz, Rahul, Mahino Fatima, Swaleha Naseem, Wasi Khan, Amal Chandra Mondal, Yasir Hasan Siddiqu. Ropinirole silver nanocomposite attenuates neurodegeneration in the transgenic Drosophila melanogaster model of Parkinson's disease. Neuropharmacology. vol 177. 2021-08-12. PMID:32707222. |
parkinson's disease (pd) is a progressive neurodegenerative disease due to the degeneration of dopaminergic neurons in substantia nigra pars compacta of the mid brain. |
2021-08-12 |
2023-08-13 |
drosophila_melanogaster |
| Yeojin Bang, Juhee Lim, Hyun Jin Cho. Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson's disease: clues to early diagnosis and effective treatment. Archives of pharmacal research. vol 44. issue 6. 2021-08-04. PMID:34145553. |
parkinson's disease (pd) is a progressive neurodegenerative disease characterized by movement dysfunction due to selective degeneration of dopaminergic neurons in the substantia nigra pars compacta. |
2021-08-04 |
2023-08-13 |
Not clear |
| Cui Liu, Yan Xue, Mei-Fang Liu, Ying Wang, Lei Che. Orexin and Parkinson's disease: A protective neuropeptide with therapeutic potential. Neurochemistry international. vol 138. 2021-07-30. PMID:32422324. |
parkinson's disease (pd) is the second most common neurodegenerative disease caused by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta. |
2021-07-30 |
2023-08-13 |
Not clear |
| Debapriya Garabadu, Nidhi Agrawa. Naringin Exhibits Neuroprotection Against Rotenone-Induced Neurotoxicity in Experimental Rodents. Neuromolecular medicine. vol 22. issue 2. 2021-07-19. PMID:31916219. |
parkinson's disease (pd) is a neurodegenerative disease that is accompanied with the loss of dopaminergic neurons in the substantia nigra pars compacta which subsequently leads to a reduction in the dopamine level in the striatum. |
2021-07-19 |
2023-08-13 |
rat |
| Liping Bai, Fang Yan, Ruhua Deng, Rou Gu, Xianwen Zhang, Jie Ba. Thioredoxin-1 Rescues MPP Molecular neurobiology. vol 58. issue 7. 2021-07-06. PMID:33634378. |
thioredoxin-1 rescues mpp parkinson's disease (pd), a common neurodegenerative disease, is typically associated with the loss of dopaminergic neuron in the substantia nigra pars compacta (snpc). |
2021-07-06 |
2023-08-13 |
Not clear |
| Fatih Soke, Bilge Kocer, Isil Fidan, Pembe Keskinoglu, Arzu Guclu-Gundu. Effects of task-oriented training combined with aerobic training on serum BDNF, GDNF, IGF-1, VEGF, TNF-α, and IL-1β levels in people with Parkinson's disease: A randomized controlled study. Experimental gerontology. vol 150. 2021-07-02. PMID:33965556. |
parkinson's disease (pd) is a chronic neurodegenerative disease characterized by the death of dopaminergic neurons in the substantia nigra pars compacta. |
2021-07-02 |
2023-08-13 |
Not clear |
| Maria Regoni, Stefano Cattaneo, Daniela Mercatelli, Salvatore Novello, Alice Passoni, Renzo Bagnati, Enrico Davoli, Laura Croci, Gian Giacomo Consalez, Federica Albanese, Letizia Zanetti, Maria Passafaro, Giulia Maia Serratto, Alessio Di Fonzo, Flavia Valtorta, Andrea Ciammola, Stefano Taverna, Michele Morari, Jenny Sasson. Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity. Cell death & disease. vol 11. issue 11. 2021-04-28. PMID:33173027. |
mutations in the park2 gene encoding the protein parkin cause autosomal recessive juvenile parkinsonism (arjp), a neurodegenerative disease characterized by dysfunction and death of dopamine (da) neurons in the substantia nigra pars compacta (snc). |
2021-04-28 |
2023-08-13 |
mouse |
| Alexandra Petie. Current and Emerging MR Methods and Outcome in Rodent Models of Parkinson's Disease: A Review. Frontiers in neuroscience. vol 15. 2021-04-28. PMID:33897339. |
parkinson's disease (pd) is a major neurodegenerative disease characterized by massive degeneration of the dopaminergic neurons in the substantia nigra pars compacta, α-synuclein-containing lewy bodies, and neuroinflammation. |
2021-04-28 |
2023-08-13 |
Not clear |
| Meritxell Pons-Espinal, Lucas Blasco-Agell, Antonella Consigli. Dissecting the non-neuronal cell contribution to Parkinson's disease pathogenesis using induced pluripotent stem cells. Cellular and molecular life sciences : CMLS. vol 78. issue 5. 2021-03-29. PMID:33210214. |
parkinson's disease (pd) is an incurable age-linked neurodegenerative disease with characteristic movement impairments that are caused by the progressive loss of dopamine-containing neurons (dan) within the substantia nigra pars compacta. |
2021-03-29 |
2023-08-13 |
human |